Appili Therapeutics Corrects Shareholder Payout Terms
Company Announcements

Appili Therapeutics Corrects Shareholder Payout Terms

Story Highlights

Appili Therapeutics Inc Class A (TSE:APLI) has released an update.

Appili Therapeutics Inc. has issued a correction to a previous press release regarding the proposed financial terms of their arrangement with Aditxt, Inc. The corrected terms now state that shareholders will receive $0.0467 in cash per Class A common share instead of the previously stated $0.467. This amendment alters the cash consideration but leaves the rest of the initial release unchanged.

For further insights into TSE:APLI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskAppili Shareholders Approve Acquisition by Aditxt
TheFlyAditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
TipRanks Canadian Auto-Generated NewsdeskAppili Therapeutics’ FDA Alignment and Aditxt Acquisition
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App